Olema pharmaceuticals inc.

Major-Pharmaceuticals

OLMA


Executive/
Director

Price

  • Last Close
  • $ 9.44
    $ -2.11 -18.27 %
    Dec 9, 2024
  • 52-Week High/Low
  • $17.14 - $9.61
  • YTD
  • -32.7%

  • Trading Volume
  • 26,335
  • Market Cap Full
  • $ 517M
  • Shares Outstanding
  • 54.8M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% -39% -56.1% 41.6% -19.3%
Q2 - - - - - 4% -8.7% -2.4% 160.2% -0.5%
Q3 - - - - - 8% -1.5% -32.2% 36.8% -
Q4 - - - - - 2.5% -65.6% -11.2% 20.3% -
J F M A M J J A S O N D
2024 -7.1% -4.9% -8.7% -4.2% - - - - - - - -
2023 97.1% -15.1% -15.4% 38% 7.9% 74.7% -4.2% 17.3% 21.7% 7.6% 5% 0.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-81%-74%473%-33%

Earnings

2019 2020 2021 2022 2023
Q1 - - -0.39 -0.58 -0.70
Q2 - - -0.42 -0.82 -0.49
Q3 - - -0.45 -0.57 -0.48
Q4 - - -0.54 -0.65 -
A -1.7 -3.4 -1.8 -2.6 -1.67

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 40.3 40.6
Jun 40.2 40.4 40.8
Sep 39.6 40.4 41.4
Dec 40.3 40.5 54.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 53.5 - - - -
Equity multiplier - - - - -